Research & Development
Postdoc in Neuropharmacology at Department of Drug Design and Pharmacology
Summary
Characterize the neuropharmacology of CaMKIIa using in-house compounds through mouse in vivo studies and tissue- and cell-based analyses. The role also includes supervising students and departmental teaching.
Read by AI
Opportunity summary
We are looking for a highly motivated and dynamic postdoc for a 2 year position to commence 1/1-2027. The position concerns pharmacological studies of an important regulator of synaptic plasticity in the mammalian brain. Information about the research group and work place can be found at the lab (Wellendorph lab) and department (www.drug.ku.dk) websites.
Our research Our lab is devoted to understanding brain mechanisms involving the inhibitory neurotransmitter GABA (γ-aminobutyric acid) and its metabolite GHB (γ-hydroxybutyric acid) via their actions on their respective targets, including CaM-responsive kinase CaMKIIa.
We use biochemical and pharmacological analyses in cells, tissues and whole organisms to elucidate the role of GHB and GABA targets in brain dysfunction. The lab spans over many different techniques and backgrounds, making it a highly interdisciplinary work environment. In the group we value social interaction, openness and teamwork, with room for ambition and scientific excitement.
Your job This specific postdoc project seeks to characterize the neuropharmacology of the target CaMKIIa using in-house generated compounds. This entails studies in vivo in mice as well as tissue- and cell-based biochemical and pharmacological analyses1 …
This is a shortened extract from the public vacancy. Follow the original posting for the complete and authoritative description.